Combating Antimicrobial Resistance by Employing Antimicrobial Peptides : Immunomodulators and Therapeutic Agents against Infectious Diseases
The rising prevalence of multiple-drug-resistant pathogens poses a formidable challenge to conventional antimicrobial treatments. The inability of potent antibiotics to combat these "superbugs" underscores the pressing need for alternative therapeutic agents. Antimicrobial peptides (AMPs) represent an alternative class of antibiotics. AMPs are essential immunomodulatory molecules that are found in various organisms. They play a pivotal role in managing microbial ecosystems and bolstering innate immunity by targeting and eliminating invading microorganisms. AMPs also have applications in the agriculture sector by combating animal as well as plant pathogens. AMPs can be exploited for the targeted therapy of various diseases and can also be used in drug-delivery systems. They can be used in synergy with current treatments like antibiotics and can potentially lead to a lower required dosage. AMPs also have huge potential in wound healing and regenerative medicine. Developing AMP-based strategies with improved safety, specificity, and efficacy is crucial in the battle against alarming global microbial resistance. This review will explore AMPs' increasing applicability, their mode of antimicrobial activity, and various delivery systems enhancing their stability and efficacy.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:7 |
---|---|
Enthalten in: |
ACS applied bio materials - 7(2024), 4 vom: 15. Apr., Seite 2023-2035 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Mehraj, Insha [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 16.04.2024 Date Revised 16.04.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1021/acsabm.3c01104 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM370234006 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM370234006 | ||
003 | DE-627 | ||
005 | 20240416232836.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240328s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1021/acsabm.3c01104 |2 doi | |
028 | 5 | 2 | |a pubmed24n1377.xml |
035 | |a (DE-627)NLM370234006 | ||
035 | |a (NLM)38533844 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Mehraj, Insha |e verfasserin |4 aut | |
245 | 1 | 0 | |a Combating Antimicrobial Resistance by Employing Antimicrobial Peptides |b Immunomodulators and Therapeutic Agents against Infectious Diseases |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 16.04.2024 | ||
500 | |a Date Revised 16.04.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a The rising prevalence of multiple-drug-resistant pathogens poses a formidable challenge to conventional antimicrobial treatments. The inability of potent antibiotics to combat these "superbugs" underscores the pressing need for alternative therapeutic agents. Antimicrobial peptides (AMPs) represent an alternative class of antibiotics. AMPs are essential immunomodulatory molecules that are found in various organisms. They play a pivotal role in managing microbial ecosystems and bolstering innate immunity by targeting and eliminating invading microorganisms. AMPs also have applications in the agriculture sector by combating animal as well as plant pathogens. AMPs can be exploited for the targeted therapy of various diseases and can also be used in drug-delivery systems. They can be used in synergy with current treatments like antibiotics and can potentially lead to a lower required dosage. AMPs also have huge potential in wound healing and regenerative medicine. Developing AMP-based strategies with improved safety, specificity, and efficacy is crucial in the battle against alarming global microbial resistance. This review will explore AMPs' increasing applicability, their mode of antimicrobial activity, and various delivery systems enhancing their stability and efficacy | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a antibacterial | |
650 | 4 | |a antibiofilm | |
650 | 4 | |a antifungal | |
650 | 4 | |a antimicrobial peptides | |
650 | 4 | |a antimicrobial resistance | |
650 | 4 | |a antiviral | |
650 | 4 | |a delivery systems | |
650 | 4 | |a immunomodulatory | |
650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
650 | 7 | |a Antimicrobial Peptides |2 NLM | |
650 | 7 | |a Antimicrobial Cationic Peptides |2 NLM | |
650 | 7 | |a Anti-Infective Agents |2 NLM | |
650 | 7 | |a Immunologic Factors |2 NLM | |
650 | 7 | |a Adjuvants, Immunologic |2 NLM | |
700 | 1 | |a Hamid, Aflaq |e verfasserin |4 aut | |
700 | 1 | |a Gani, Ubaid |e verfasserin |4 aut | |
700 | 1 | |a Iralu, Nulevino |e verfasserin |4 aut | |
700 | 1 | |a Manzoor, Tasaduq |e verfasserin |4 aut | |
700 | 1 | |a Saleem Bhat, Sahar |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t ACS applied bio materials |d 2018 |g 7(2024), 4 vom: 15. Apr., Seite 2023-2035 |w (DE-627)NLM287335372 |x 2576-6422 |7 nnns |
773 | 1 | 8 | |g volume:7 |g year:2024 |g number:4 |g day:15 |g month:04 |g pages:2023-2035 |
856 | 4 | 0 | |u http://dx.doi.org/10.1021/acsabm.3c01104 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 7 |j 2024 |e 4 |b 15 |c 04 |h 2023-2035 |